All members have the option of attending our various HTC-centric events which include:
Date: Monday, November 27, 2023
Time: 1:00pm – 2:00pm ET
TITLE:
A different treatment option for Inhibitor patients
OBJECTIVE:
This presentation will provide an overview of inhibitors and explore the efficacy, safety, tolerability, clinical development, and reasons to consider a different treatment option.
TARGET AUDIENCE:
All HTC Staff
SPEAKER:
Guy Young, MD.
Director, Hemostasis and Thrombosis Center
Director, Clinical Coagulation Laboratory Cancer and Blood Disorders Institute Children’s Hospital Los Angeles
Professor of Pediatrics, University of Southern California Keck School of Medicine
